美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NewcelX Ltd.

7.29

-0.3300-4.33%

盤後：6.91-0.3800-5.21%19:59 EDT

成交量：124.69萬

成交額：741.72萬

市值：3,323.07萬

市盈率：-0.28

高：7.64

開：5.08

低：4.20

收：7.62

52周最高：47.40

52周最低：4.20

股本：455.84萬

流通股本：455.84萬

量比：0.10

換手率：27.35%

股息：- -

股息率：- -

每股收益(TTM):-26.2880

每股收益(LYR):-26.2880

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-0.28

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

NewcelX Ltd.

交易所：

NASDAQ

成立時間：

2008

員工人數：

13

公司地址：

Pinchas Sapir 7,Ness Ziona,Israel

官網：

http://www.nlspharma.com

郵編：

74140

電話：

972 73 797 1600

傳真：

972 8 910 0698

簡介：

NLS Pharmaceutics Ltd.於2015年6月成立。該公司是一家創新的生物製藥公司，致力於發現和開發可改善罕見中樞神經系統疾病的改善生命的藥物療法。

董事

名稱

職位

Ronen Twito

Executive Chairman and Chief Executive Officer

Eran Iohan

Independent Director

Liora Oren

Independent Director

Michel Revel

Chief Scientific Officer and Director

Olivier Samuel

Independent Director

Alexander Zwyer

Director

Tammy Galili

Director

股東

名稱

職位

Ronen Twito

Executive Chairman and Chief Executive Officer

Uri Ben Or

Chief Financial Officer

Ariel Revel

Director of Medical Affairs

Eric Konofal

Chief Scientific Officer

Kfir Molakandov

Vice President of Research and Development

Michel Revel

Chief Scientific Officer and Director

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NCEL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NCEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","market":"US","secType":"STK","nameCN":"NewcelX Ltd.","latestPrice":7.29,"timestamp":1761940800000,"preClose":7.62,"halted":0,"volume":1246926,"hourTrading":{"tag":"盘后","latestPrice":6.91,"preClose":7.29,"latestTime":"19:59 EDT","volume":47718,"amount":345479.7893,"timestamp":1761955177846},"delay":0,"floatShares":4558400,"shares":4558400,"eps":-26.28804,"marketStatus":"已收盤","change":-0.33,"latestTime":"10-31 16:00:00 EDT","open":5.08,"high":7.64,"low":4.2,"amount":7417237.8112236,"amplitude":0.451444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-26.28804,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":5,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":7.62,"preHourTrading":{"tag":"盘前","latestPrice":5.26,"preClose":7.62,"latestTime":"09:29 EDT","volume":179418,"amount":1052985.1519248,"timestamp":1761917396617},"postHourTrading":{"tag":"盘后","latestPrice":6.91,"preClose":7.29,"latestTime":"19:59 EDT","volume":47718,"amount":345479.7893,"timestamp":1761955177846},"volumeRatio":0.10434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","floatShares":4558400,"roa":"--","roe":"--","lyrEps":-26.28804,"volumeRatio":0.10434,"shares":4558400,"dividePrice":0,"high":7.64,"amplitude":0.451444,"preClose":7.62,"low":4.2,"week52Low":4.2,"pbRate":"--","week52High":47.4,"institutionHeld":0,"latestPrice":7.29,"eps":-26.28804,"divideRate":0,"volume":1246926,"delay":0,"ttmEps":-26.28804,"open":5.08,"prevYearClose":2.11,"prevWeekClose":1.3,"prevMonthClose":1.83,"prevQuarterClose":1.83,"fiveDayClose":1.3,"twentyDayClose":1.995,"sixtyDayClose":2.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NCEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-31","symbol":"NCEL","defaultRemindTime":1761917400000,"type":"split","dateTimestamp":1761883200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-16","symbol":"NCEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747368000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-09-27","symbol":"NCEL","defaultRemindTime":1727443800000,"type":"split","dateTimestamp":1727409600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NCEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NCEL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":224505747,"yearFounded":2008,"employeeNum":13,"address":"Pinchas Sapir 7,Ness Ziona,Israel","zipCode":"74140","officePhone":"972 73 797 1600","officeFax":"972 8 910 0698"},"stockCompanyDetail":{"websiteUrl":"http://www.nlspharma.com","compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0205},{"period":"3month","weight":0.0935},{"period":"6month","weight":0.1995},{"period":"1year","weight":0.1721},{"period":"ytd","weight":0.16}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"NLS Pharmaceutics Ltd.於2015年6月成立。 該公司是一家創新的生物製藥公司，致力於發現和開發可改善罕見中樞神經系統疾病的改善生命的藥物療法。","exchange":"NASDAQ","name":"NewcelX Ltd.","nameEN":"NewcelX Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NCEL\",market:\"US\",,,undefined,":{"directors":[{"name":"Ronen Twito","position":"Executive Chairman and Chief Executive Officer"},{"name":"Eran Iohan","position":"Independent Director"},{"name":"Liora Oren","position":"Independent Director"},{"name":"Michel Revel","position":"Chief Scientific Officer and Director"},{"name":"Olivier Samuel","position":"Independent Director"},{"name":"Alexander Zwyer","position":"Director"},{"name":"Tammy Galili","position":"Director"}],"executives":[{"name":"Ronen Twito","position":"Executive Chairman and Chief Executive Officer"},{"name":"Uri Ben Or","position":"Chief Financial Officer"},{"name":"Ariel Revel","position":"Director of Medical Affairs"},{"name":"Eric Konofal","position":"Chief Scientific Officer"},{"name":"Kfir Molakandov","position":"Vice President of Research and Development"},{"name":"Michel Revel","position":"Chief Scientific Officer and Director"}]}}}